PreventionGenetics launches PGxome tests to benefit reproductive and healthy patients

“PreventionGenetics is a thought leader in genetic testing. Our suite of PGxome tests provides options for a variety of patients, including those in the reproductive arena,” said James Weber, PhD, founder and president of PreventionGenetics. “With the cost of sequencing continuing to decline, patients and providers now have access to more complete genetic testing, with the same high quality they have come to expect from us. Rather than settling for tests that analyze limited conditions and genetic variants, they now have options for full gene sequencing of essentially all clinically relevant genes.”
 
PGxome Health Screen is intended for healthy patients who want to learn their carrier status for recessive disorders and/or their susceptibility to adult onset conditions. Unlike common carrier screening tests, we sequence the full gene rather than limiting analysis to common disease causing variants within each gene. PreventionGenetics identifies and interprets all sequence variants (differences between the patient's sequence and the reference sequence) but only reports Pathogenic and Likely Pathogenic variants, meaning they are expected, with a high degree of certainty, to be disease causing.
 
What sets PreventionGenetics’ PGxome tests apart is distributed variant interpretation. “Clinically relevant genes and their variants are interpreted by MD and PhD Geneticists who have specialization and expertise in specific disease categories” said Weber. “Our specialty-focused approach harnesses the collective knowledge and experience of many Geneticists in collaboration, and through the power of many, we are able to accurately interpret the patient’s results.”

Preventiongenetics launches, pgxome tests, benefit reproductive and healthy patients